• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经手术切除贲门腺癌后的结局

Outcomes After Resection of Adenocarcinoma of the Gastric Cardia by Surgical Approach.

作者信息

Bates Kelly R, Jacobs Ryan C, Zaza Norah N, Liggett Marjorie R, Rao Saieesh A, Vitello Dominic J, Bentrem David J

机构信息

Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Department of Surgery, Jesse Brown Veterans Administration Medical Center, Chicago, IL, USA.

出版信息

Ann Surg Oncol. 2025 May 8. doi: 10.1245/s10434-025-17431-5.

DOI:10.1245/s10434-025-17431-5
PMID:40338422
Abstract

BACKGROUND

Total gastrectomy and esophagectomy are commonly used surgical approaches for cardia gastric adenocarcinoma (GA) resection. However, the preferred approach remains unclear. The objectives of this study were to identify predictors of receipt of surgical approach type and compare surgical approach outcomes.

PATIENTS AND METHODS

Patients with stage IB-IIIC cardia GA from 2004 to 2017 were identified within the National Cancer Database. Patients were compared on the basis of receipt of total gastrectomy versus partial gastrectomy with esophagectomy. Predictors of receiving esophagectomy were identified using multivariable logistic regression. Predictors associated with overall survival (OS) were assessed using a multivariable Cox proportional hazards model.

RESULTS

A total of 9841 patients were included. More patients underwent esophagectomy compared with total gastrectomy (77.2% vs. 22.8%). Surgical approach utilization did not vary significantly over time (p = 0.6). Patients who were non-white or female (OR 0.8, 95% CI 0.7-0.9) were less likely to receive esophagectomy. The median number of lymph nodes resected was greater for total gastrectomy versus esophagectomy (18 vs. 15, p < 0.01). There was no difference in resection margins (93.6% vs. 94.5%, p = 0.3) or 30-day mortality (3.0% vs. 2.5%, p = 0.2). Total gastrectomy and esophagectomy had similar OS (40.2 vs. 40.1 months, p = 0.7). On multivariate analysis, there was no difference in survival for total gastrectomy versus esophagectomy (HR 1.0, 95% CI 0.9-1.0).

CONCLUSIONS

Utilization of total gastrectomy and esophagectomy has remained stable over time with esophagectomy being more utilized. These approaches exhibit similar oncologic outcomes for proximal GA. Surgeons should consider long-term outcomes, such as quality of life and nutritional status, when selecting an approach.

摘要

背景

全胃切除术和食管切除术是贲门胃腺癌(GA)切除常用的手术方式。然而,首选的手术方式仍不明确。本研究的目的是确定手术方式类型选择的预测因素,并比较手术方式的结果。

患者与方法

在国家癌症数据库中识别出2004年至2017年患有IB-IIIC期贲门GA的患者。根据接受全胃切除术与部分胃切除术加食管切除术的情况对患者进行比较。使用多变量逻辑回归确定接受食管切除术的预测因素。使用多变量Cox比例风险模型评估与总生存期(OS)相关的预测因素。

结果

共纳入9841例患者。与全胃切除术相比,接受食管切除术的患者更多(77.2%对22.8%)。手术方式的使用随时间变化无显著差异(p = 0.6)。非白人或女性患者接受食管切除术的可能性较小(比值比0.8,95%置信区间0.7-0.9)。全胃切除术切除的淋巴结中位数多于食管切除术(18对15,p < 0.01)。切缘情况(93.6%对94.5%,p = 0.3)或30天死亡率(3.0%对2.5%,p = 0.2)无差异。全胃切除术和食管切除术的总生存期相似(40.2个月对40.1个月,p = 0.7)。多变量分析显示,全胃切除术与食管切除术的生存率无差异(风险比1.0,95%置信区间0.9-1.0)。

结论

随着时间推移,全胃切除术和食管切除术的使用保持稳定,且食管切除术的使用更为普遍。这些手术方式对近端GA显示出相似的肿瘤学结果。外科医生在选择手术方式时应考虑长期结果,如生活质量和营养状况。

相似文献

1
Outcomes After Resection of Adenocarcinoma of the Gastric Cardia by Surgical Approach.经手术切除贲门腺癌后的结局
Ann Surg Oncol. 2025 May 8. doi: 10.1245/s10434-025-17431-5.
2
[Application research of endoscopic-laparoscopic regional gastric resection combined with sentinel lymph node basin dissection in patients with early gastric cancer].内镜-腹腔镜区域胃切除术联合前哨淋巴结清扫在早期胃癌患者中的应用研究
Zhonghua Wai Ke Za Zhi. 2025 Jul 1;63(7):587-596. doi: 10.3760/cma.j.cn112139-20250117-00034.
3
Laparoscopic versus open gastrectomy for gastric cancer.腹腔镜与开腹胃癌切除术对比
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD011389. doi: 10.1002/14651858.CD011389.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Complications Following Open Versus Minimally Invasive Resection of Gastric Adenocarcinoma.胃腺癌开放手术与微创手术切除后的并发症
J Surg Oncol. 2025 Jun;131(7):1302-1312. doi: 10.1002/jso.28073. Epub 2025 Jan 9.
7
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
8
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.局部进展期胃或胃食管交界腺癌患者行D2胃切除术后围手术期或术后辅助使用奥沙利铂联合S-1与奥沙利铂联合卡培他滨的疗效比较(RESOLVE):一项随机、开放标签、3期试验的最终报告
Lancet Oncol. 2025 Mar;26(3):312-319. doi: 10.1016/S1470-2045(24)00676-4. Epub 2025 Feb 11.
9
Surgery for weight loss in adults.成人减肥手术。
Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4.
10
Long-term outcomes of proximal gastrectomy versus total gastrectomy for clinically advanced upper-third gastric cancer: an inverse probability weighting analysis.近端胃切除术与全胃切除术治疗临床晚期胃上部癌的长期疗效:逆概率加权分析
World J Surg Oncol. 2025 Jul 18;23(1):288. doi: 10.1186/s12957-025-03946-4.

本文引用的文献

1
Quality of Life and Nutritional Outcomes of Stomach-Preserving Surgery for Early Gastric Cancer: A Secondary Analysis of the SENORITA Randomized Clinical Trial.保留胃的早期胃癌手术的生活质量和营养结局:SENORITA 随机临床试验的二次分析。
JAMA Surg. 2024 Aug 1;159(8):900-908. doi: 10.1001/jamasurg.2024.1210.
2
ARE THERE ADVANTAGES IN DOUBLE TRANSIT RECONSTRUCTION AFTER TOTAL GASTRECTOMY IN PATIENTS WITH GASTRIC CANCER? A SYSTEMATIC REVIEW.全胃切除术后双重转运重建在胃癌患者中的优势:系统评价。
Arq Bras Cir Dig. 2024 May 13;37:e1799. doi: 10.1590/0102-672020240006e1799. eCollection 2024.
3
Roux-en-Y with or without jejunal J-pouch reconstruction after total gastrectomy for gastric cancer: systematic review and meta-analysis of long-term functional outcomes.
胃切除术后 Roux-en-Y 吻合术与或不与空肠 J 袢重建用于胃癌:长期功能结局的系统评价和荟萃分析。
J Gastrointest Surg. 2024 Mar;28(3):291-300. doi: 10.1016/j.gassur.2023.12.015. Epub 2024 Jan 19.
4
Systematic review of quality of life after esophagectomy and total gastrectomy in patients with gastro-esophageal junction cancer.胃食管结合部癌患者行食管切除术和全胃切除术的生活质量系统评价。
Dis Esophagus. 2023 Nov 30;36(12). doi: 10.1093/dote/doad039.
5
Oesophagectomy or Total Gastrectomy for the Management of Siewert II Gastroesophageal Junction Cancer: a Systematic Review and Meta-analysis.Siewert II 型胃食管结合部腺癌行食管切除术或全胃切除术的疗效比较:系统评价和荟萃分析。
J Gastrointest Surg. 2023 Jul;27(7):1321-1335. doi: 10.1007/s11605-023-05661-5. Epub 2023 Apr 3.
6
Laparoscopic Function-Preserving Gastrectomy for Proximal Gastric Cancer or Esophagogastric Junction Cancer: A Narrative Review.腹腔镜保留功能的近端胃癌或食管胃交界癌胃切除术:一项叙述性综述
Cancers (Basel). 2023 Jan 3;15(1):311. doi: 10.3390/cancers15010311.
7
Ongoing Controversies in Esophageal Cancer II: Gastrectomy versus Esophagectomy for Siewert Type II Esophageal Adenocarcinoma.食管癌研究进展 II:Siewert Ⅱ型食管胃腺癌行胃切除术还是食管切除术?
Thorac Surg Clin. 2022 Nov;32(4):553-563. doi: 10.1016/j.thorsurg.2022.07.004.
8
Incidence, Timing, and Outcomes of Venous Thromboembolism in Patients Undergoing Surgery for Esophagogastric Cancer: A Population-Based Cohort Study.接受食管癌和胃癌手术患者静脉血栓栓塞的发生率、发生时间及结局:一项基于人群的队列研究
Ann Surg Oncol. 2022 Mar 12. doi: 10.1245/s10434-022-11520-5.
9
Lymph Node Evaluation after Neoadjuvant Chemotherapy for Patients with Gastric Cancer.胃癌患者新辅助化疗后的淋巴结评估
Ann Surg Oncol. 2022 Feb;29(2):1242-1253. doi: 10.1245/s10434-021-10803-7. Epub 2021 Oct 3.
10
Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study.胸腹腔镜联合与经胸经裂孔食管胃切除术治疗食管胃结合部腺癌术后并发症的前瞻性全国多中心研究
Gastric Cancer. 2022 Mar;25(2):430-437. doi: 10.1007/s10120-021-01255-9. Epub 2021 Sep 30.